logo
NewPhase3DataShowTakeda’sDengueVaccineDelivers7YearsofSustainedProtectionAgainstInfectionandHospitalization
===2025/11/4 10:15:35===
ding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business; the timing and impact of post-merger integration efforts with acquired companies; the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s); and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at:https://www.takeda.com/investors/sec-filings-and-security-reports/or atwww.sec.gov. Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past pe
=*=*=*=*=*=
当前为第18/21页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页